Clopidogrel non-ST-segment elevation ACS Treatment.docVIP

 PAGE \* MERGEFORMAT 11 Clopidogrel non-ST-segment elevation ACS Treatment 【Abstract】 Objective To observe the Plavix (clopidogrel) in non-ST segment elevation acute coronary syndrome (ACS) in effect. Method two groups were given aspirin, low molecular weight heparin, nitroglycerin, β-blockers such as conventional treatment, A group received clopidogrel 75mg, 1 times / d, followed up for 1 year; control group, B group given placebo was observed cardiovascular events, sudden death, stroke, and the incidence of upper gastrointestinal bleeding. Results Plavix (clopidogrel) group cardio-cerebral vascular events occurred in 6 cases (6.8%), upper gastrointestinal bleeding in 1 case, while the placebo group cardio-cerebral vascular events occurred in 25 cases (22.3%), the difference There was a significant (P lt;0.05). Conclusion Clopidogrel in non-ST segment elevation ACS have a good effect. Keywords: clopidogrel (Plavix); platelet; acute coronary syndrome 【Abstract】 Objective Observation the curative effect of clopidogrel on the NSTEMI ACS. Methods Two groups general treat by asprin, low molecular heparin, glyceryl trinitrate, β-blocker, group A given by clopidogrel 75mg qd, allow search for one year; comparison group B given by console dose, observe the heart atherothrombotic event, abrupt die, cerebral accidente, alimentary tract bleeding. Results group of clopidogrel all happened 6 accidents (6.8%), 1 case happened alimentary tract bleeding. Group B have 25 accidents (22.3% ). Two groups have notability difference (P lt;0.05). Conclusion Clopidogrel have better effect on the treatment in NSTEMI ACS. 【Keywords:】 Clopidogrel; platelets; ACS Acute coronary syndrome (ACS), including the mechanism of inflammation, plaque fracture and subsequent thrombosis. For ST segment elevation of the ACS (most developed ST-segment elevation myocardial infarction or STEMI) and non-ST segment elevation of the ACS, which includes unstable angina (U